Neonatal screening for biotinidase deficiency in east-Hungary

There are two types of multiple carboxylase deficiency, the neonatal form with holocarboxylase synthetase defect and the late-onset form with biotinidase deficiency. We report our preliminary experiences in screening for biotinidase deficiency. In total 43,493 infants were screened for the deficienc...

Full description

Saved in:
Bibliographic Details
Published inJournal of inherited metabolic disease Vol. 14; no. 6; p. 928
Main Author Havass, Z
Format Journal Article
LanguageEnglish
Published United States 01.11.1991
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:There are two types of multiple carboxylase deficiency, the neonatal form with holocarboxylase synthetase defect and the late-onset form with biotinidase deficiency. We report our preliminary experiences in screening for biotinidase deficiency. In total 43,493 infants were screened for the deficiency of the enzyme biotinidase; 0.14% false positive results that necessitated requests for second blood samples and two newborns with a biotinidase defect were identified during our pilot study. The definitive diagnosis required the demonstration of enzyme deficiency in serum. Both of the patients have residual biotinidase activity: 3.59% and 7.55%. These two newborns with biotinidase deficiency are treated with daily supplementation of free biotin. According to our preliminary results biotinidase deficiency satisfies all the criteria for incorporation into the national newborn mass screening.
ISSN:0141-8955
DOI:10.1007/BF01800476